All In MedTech

FDA Clearance Tracker · P100030-S018

Preveleak Surgical Sealant, Preveleak I 0-pack delivery tips

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 29, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 29, 2023

Approved

Time to decision

29 days

Received Oct 31, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P100030-S018
Device name
Preveleak Surgical Sealant, Preveleak I 0-pack delivery tips
Applicant location
Deerfield Lake, IL
Received
Oct 31, 2023
Decided
Nov 29, 2023
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P100030

Device type

Device class
Class III

Every decision under product code NBE

FDA's approval statement

As written in FDA's record.

Approval for a manufacturing site located at Hayward, California to manufacture the Preveleak Sealant, 4mL and delivery tips.

Source documents

Other decisions for Baxter Healthcare Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.